Civik Thomas bought PYXS
September 4, 2026 · Form 4 insider transaction
Civik Thomas bought 2,503,050 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,503,050
Price
$0.00
Total value
N/A
InsiderCivik Thomas
RoleOfficer, Director
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 4, 2026
Filing dateSeptember 8, 2026
Shares owned after2,503,050
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of September 4, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.